ChampionX Corp (CHX) concluded trading on Wednesday at a closing price of $28.26, with 4.42 million shares of worth about $124.94 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -9.22% during that period and on March 05, 2025 the price saw a gain of about 1.00%. Currently the company’s common shares owned by public are about 190.70M shares, out of which, 188.23M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 0 times over the past 12 months. They bought 0 shares in 0 of the transactions. In 0 selling transactions, insiders dumped 0 shares.
Stock saw a price change of -2.15% in past 5 days and over the past one month there was a price change of -0.95%. Year-to-date (YTD), CHX shares are showing a performance of 3.94% which decreased to -11.38% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $25.57 but also hit the highest price of $39.95 during that period. The average intraday trading volume for ChampionX Corp shares is 2.69 million. The stock is currently trading -3.41% below its 20-day simple moving average (SMA20), while that difference is down -1.39% for SMA50 and it goes to -7.55% lower than SMA200.
ChampionX Corp (NASDAQ: CHX) currently have 190.70M outstanding shares and institutions hold larger chunk of about 91.70% of that.
The stock has a current market capitalization of $5.39B and its 3Y-monthly beta is at 1.88. PE ratio of stock for trailing 12 months is 17.08, while it has posted earnings per share of $1.65 in the same period. It has Quick Ratio of 1.36 while making debt-to-equity ratio of 0.41. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CHX, volatility over the week remained 4.27% while standing at 3.07% over the month.
Stock’s fiscal year EPS is expected to drop by -7.38% while it is estimated to increase by 14.30% in next year.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Piper Sandler on January 08, 2024 offering a Neutral rating for the stock and assigned a target price range of between $38 and $32 to it. Coverage by Barclays stated ChampionX Corp (CHX) stock as an Overweight in their note to investors on October 17, 2023, suggesting a price target of $42 for the stock. On July 14, 2023, CapitalOne Initiated their recommendations, while on October 06, 2022, Barclays Downgrade their ratings for the stock with a price target of $28. Stock get a Buy rating from The Benchmark Company on August 25, 2022.
